Treatment Registry
TR-0489 ActiveRecorded September 2026

Compounded semaglutide

Sold by RestorLife Med · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

Initial payment · 3-month plan

$168

Monthly equivalent

$56

initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · GLP-1 Microdose, 3 month (list $113/mo) · recorded upfront charge for 3 months$168

Added from the figures recorded below.

Price

TermPer monthCharged today
GLP-1 Protocol, 3 month (list $299/mo)

“3 month $209 $299 /mo”

Per month$209Charged today$627
GLP-1 Microdose, 3 month (list $113/mo)

“3 month $56 $113 /mo”

Per month$56Charged today$168
GLP-1 Protocol, 6 month (list $299/mo)

“6 month $199 $299 /mo”

Per month$199Charged today$1,194
Price sources
Visit RestorLife Med

We earn nothing from this link. It opens RestorLife Med's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberBoth
CancellationCan I cancel anytime? Yes. There are no long-term contracts or commitments. You can pause or cancel your membership at any time through your patient portal or by contacting our support team.

Not yet checked: pharmacy, membership and consult fee.

Recorded from restorlifemed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Prices are for a first-order-discounted rate shown beside a crossed-out list price (e.g. '$149 $219/mo'); both numbers were captured, with perMonth set to the actual advertised price and the list price kept in each quote. In addition to the standard-dose semaglutide/tirzepatide protocols, the site sells 'microdose' tiers of each drug at lower doses/prices, recorded as separate price entries under the same drug. The homepage names the physician as 'Licensed in all 50 states,' but that describes the physician's individual licensure, not a company-wide service-area claim — the site's own Terms of Service instead says only 'certain states' are served with no list, so states was recorded as not-found rather than all-50. RestorLife Med's telemedicine consent is issued by 'Beluga Health, P.A.' — the same Beluga Health checked separately in this batch as a B2B infrastructure vendor.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0489
Medication category
compounded semaglutide
Readings
1

Related records

Other records from RestorLife Med

All RestorLife Med programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). RestorLife Med — compounded semaglutide (TR-0489). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0489

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.